|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/19 | |
| A61K 31/7105 | |||
| C07K 14/52 | |||
| A61K 38/20 | |||
| A61K 39/00 | |||
| C12N 15/113 | |||
| C12N 15/117 | |||
| A61P 35/00 |
| (11) | Number of the document | 3326641 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17196250.9 |
| Date of filing the European patent application | 2016-04-22 | |
| (97) | Date of publication of the European application | 2018-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-26 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 15001191 | 2015-04-22 | EP |
| (72) |
Fotin-Mleczek, Mariola, DE
Kowalczyk, Aleksandra, DE
Heidenreich, Regina, DE
Baumhof, Patrick, DE
Probst, Jochen, DE
Kallen, Karl-Josef, DE
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES |
| RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES |